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        Introduction 
  Actin reorganization regulated by RhoA, a small GTPase, is 
essential for many cellular processes, including adhesion, 
rounding, migration, contraction, and proliferation (  Van Aelst 
and  D ’ Souza-Schorey,  1997 ;   Hall,  1998 ;   Aznar  and  Lacal, 
2001 ;  Etienne-Manneville and Hall, 2002 ). Rho kinase (ROCK) 
is one of the downstream effectors of RhoA signaling that 
phosphorylates myosin light chain (MLC), activating myosin 
to cross-link actin fi  laments and generating contraction force 
(  Amano et al., 1996  ;   Kimura et al., 1996  ;   Kureishi et al., 1997  ; 
  Fukata et al., 1998  ;   Feng et al., 1999  ). Two isoforms of ROCK, 
ROCKI and ROCKII, which belong to a family of serine/threonine 
kinases, are activated via interaction with RhoA GTPase (  Riento 
and Ridley, 2003  ;   Mueller et al., 2005  ). The kinase domain of 
ROCKs is localized in the N-terminal region. The C-terminal 
region of ROCKs, which contains the rho binding domain 
(RBD) and pleckstrin homology domain, is responsible for 
  autoinhibition of the kinase activity through interaction with 
the N-terminal kinase region (  Amano et al., 1999  ). Proteolytic 
cleavages of the inhibitory C-terminal region of ROCKI by 
caspase-3 (  Coleman et al., 2001  ;   Sebbagh et al., 2001  ) and of 
ROCKII by granzyme B (  Sebbagh et al., 2005  ) result in irre-
versible activation of ROCK kinases and membrane blebbing 
in apoptosis. Under the normal physiological conditions, ROCK 
is mainly regulated by binding of the GTP-bound form of RhoA 
to the RBD, which stimulates ROCK kinase activity by dis-
rupting the intramolecular interaction (  Fujisawa et al., 1996  ; 
  Dvorsky et al., 2004  ). 
 RhoA/ROCK-mediated  signaling  infl  uences the inter-
actions between the actin cytoskeleton and integrins to regulate 
integrin activity involved in cell shape and adhesive properties 
(  Cali et al., 1999  ;   Worthylake and Burridge, 2003  ;   Nelson et al., 
2004  ;   Basile et al., 2007  ). It has been shown that RhoA pro-
motes the formation of large integrin-based focal adhesions by 
increasing actomyosin-dependent integrin clustering and is re-
quired for focal adhesion complex formation during adhesion 
(  Hotchin and Hall, 1995  ;   Narumiya et al., 1997  ). In contrast, an 
excessive level of ROCK-mediated contractility is able to either 
disrupt the interaction between extracellular matrix and integrin 
or to constrain integrin mobility through enrichment of the cor-
tical actin, resulting in cell deadhesion and rounding (  Alblas 
et al., 2001  ;   Liu et al., 2002  ;   Maddox and Burridge, 2003  ). 
  During cell migration, RhoA/ROCK activation generates protru-
sive forces at the front and retraction forces at the rear (  Worthylake 
et al., 2001  ;   Kurokawa and Matsuda, 2005  ;   Wong et al., 2006  ). 
Presumably, too much ROCK activity would disrupt the adhe-
sion linkage and affect motility. Because it has been shown that 
RhoA is consistently activated in the protruding regions of ran-
domly migrating fi  broblasts (  Pertz et al., 2006  ), in this study we 
were interested in the negative control for RhoA/ROCK activa-
tion contributing to optimization of the localized contractile 
force in the adhesion and deadhesion processes. 
C
ontractile forces mediated by RhoA and Rho ki-
nase (ROCK) are required for a variety of cellular 
processes, including cell adhesion. In this study, 
we show that RhoA-dependent ROCKII activation is nega-
tively regulated by phosphorylation at a conserved tyro-
sine residue (Y722) in the coiled-coil domain of ROCKII. 
Tyrosine phosphorylation of ROCKII is increased with 
cell adhesion, and loss of Y722 phosphorylation delays 
adhesion and spreading on ﬁ  bronectin, suggesting that 
this modiﬁ  cation is critical for restricting ROCKII-mediated 
contractility during these processes. Further, we pro-
vide evidence that Shp2 mediates dephosphorylation of 
ROCKII and, therefore, regulates RhoA-induced cell 
rounding, indicating that Shp2 couples with RhoA signal-
ing to control ROCKII activation during deadhesion. Thus, 
reversible tyrosine phosphorylation confers an additional 
layer of control to ﬁ  ne-tune RhoA-dependent activation 
of ROCKII.
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tible to phorbol ester  –  induced apoptosis (  Lai et al., 2002, 2003  ; 
  Chang and Lee, 2006  ;   Chang et al., 2006  ). In this paper, we 
report that RhoA/ROCK-mediated deadhesion of D2 cells re-
quires molecular events involving tyrosine dephosphorylation. 
We also found that ROCKII is phosphorylated at the Y722 site 
during adhesion and that an Shp2-mediated dephosphorylation 
event is required for RhoA-induced deadhesion of D2 cells. 
Y722 phosphorylation decreases ROCKII binding to RhoA-GTP, 
thereby attenuating RhoA-mediated ROCKII activation. Impor-
tantly, expression of Y722F ROCKII markedly delayed D2 cells 
adhering to the fi  bronectin (FN) matrix. These results imply an-
other layer of complexity in regulating ROCKII through Y722 
phosphorylation and add Shp2 function in ROCKII activation. 
  Shp2, encoded by the   Ptpn11   gene, is a ubiquitously ex-
pressed nonreceptor protein tyrosine phosphatase (PTP) charac-
terized by having two Src homology-2 domains in the N-terminal 
region that autoinhibit its PTP catalytic function (  Chan and 
Feng, 2007  ;   Mohi and Neel, 2007  ). To become activated, Shp2 
is recruited to the membrane of tyrosine-phosphorylated docking 
proteins such as SHPS1/SIRP-1 (  Fujioka et al., 1996  ). In receptor 
tyrosine kinase signaling, Shp2 is activated by the recruitment 
of the tyrosine phosphorylated scaffolding adapters, including 
insulin receptor substrate, fibroblast growth factor receptor 
  substrate, and Gab proteins, to its N  –  Src homology-2 domain, 
causing catalytic activation of its PTP domain (  Neel et al., 2003  ). 
Fibroblasts derived from Shp2 
(   /  )  mice have been shown to have 
  At present, it is known that RhoA/ROCK signaling is 
  negatively controlled by a variety of mechanisms, including 
 cytosolic sequestration of GDP-bound RhoA by guanosine nucleo-
tide dissociation inhibitors, stimulation of the GTPase activity 
by GAPs (  Ridley, 2001  ), and local degradation of RhoA protein 
by Smurf1 in the leading edge of migrating cells (  Sahai et al., 
2007  ). In addition to these negative controls via RhoA, three 
proteins that directly inhibit ROCK function through protein 
  interaction have been described. Gem and Rad are two small 
G proteins that can directly bind and inhibit ROCK I and II, 
  respectively (  Ward et al., 2002  ). RhoE, a Rho protein which is 
defective in GTPase function, has also been shown to interact 
with ROCKI and to inhibit ROCKI-induced stress fi  ber forma-
tion (  Riento et al., 2003  ). Recent reports have further shown 
that RhoE is a target gene of p53 (  Ongusaha et al., 2006  ;   Gadea 
et al., 2007  ). In response to DNA damage, RhoE expression is 
up-  regulated so that ROCKI activity is repressed to prevent 
apoptosis (  Boswell et al., 2007  ). The delicate inhibition of 
RhoA activation and the existence of ROCK inhibitors high-
light how important it is to ensure that RhoA/ROCK is not acti-
vated at the time and places where too much contractility and 
inappropriate actin reorganization would interfere with the cel-
lular processes. 
  Our laboratory has previously used a myeloid leukemia 
cell line, D2, to show that RhoA/ROCK activation signaling 
 prevents adhesion ( Lai et al., 2001 ), rendering these cells suscep-
  Figure 1.       Involvement of tyrosine dephos-
phorylation in ROCK-dependent cell rounding.   
(A  –  C) Adherent D2 cells plated in culture dishes 
in serum-free medium for 2 h were serum stimu-
lated and treated with 300   μ  M orthovanadate 
(Na  3  VO  4  ) or 20   μ  M Y27632, followed by 
stimulation with 20% heat-inactivated serum for 
10 min. (A) Phase-contrast images of cells with 
indicated treatment. (B) Western blots of cells 
probed for phosphorylated[T 
18  /S 
19  ] and total 
MLC. (C) Endogenous RhoA activity measured 
by GST-RBD pulldown assay as described in 
Materials and methods. Values are mean   ±   SD 
of three independent experiments. (D and E) 
Cells were plated on FN-coated dishes for 2 h in 
serum-containing medium treated with 20   μ  M 
Y27632 or 300   μ  M orthovanadate, followed 
by addition of 20   μ  g/ml of TAT-RhoAV14 for 
30 min. (D) Phase-contrast images of cells. 
(E) Western blot of cells probed by antibodies 
against phospho-MLC, total MLC, and HA for 
TAT-RhoAV14. Bars, 50   μ  m.     1001 ROCKII REGULATION BY SHP2   • Lee and Chang 
inhibitor, or vanadate, a general tyrosine phosphatase inhibitor, 
prevented serum-responsive rounding (  Fig. 1 A  ). Consistent with 
the change in the cell rounding, MLC phosphorylation was 
increased by serum stimulation, and this serum-responsive altera-
tion was abolished by vanadate or Y27632 treatment (  Fig. 1 B  ). 
Serum stimulation, as expected, increased endogenous RhoA ac-
tivity; however, neither vanadate nor Y27632 treatment inhibited 
serum-responsive RhoA activation (  Fig. 1 C  ). In fact, these two 
treatments increased RhoA activity. Treatment of cells attached to 
FN-coated dish in serum-free medium with TAT-RhoAV14 pro-
tein, which is a cell-permeable dominant-active form of RhoA, 
also induced cell rounding and detachment (  Fig. 1 D  ). Again, van-
adate or Y27632 treatment prohibited TAT-RhoAV14-induced cell 
detachment and MLC phosphorylation (  Fig. 1 E  ). Together, all 
these results point out that biochemical events regulated by tyro-
sine dephosphorylation are required for RhoA/ROCK-mediated 
cell deadhesion. 
lower levels of motility with slower spreading rate (  Yu et al., 
1998  ). Experimental evidences have suggested that Shp2 regu-
lates integrin function by dephosphorylating FAK for focal adhe-
sion turnover during migration (  Manes et al., 1999  ;   von Wichert 
et al., 2003  ). Relevantly, data from this study showed that Shp2 is 
also involved in ROCKII dephosphorylation and participates in 
promoting activation of RhoA/ROCKII for cell detachment. 
  Results 
  Protein tyrosine dephosphorylation is 
required for RhoA/ROCK-mediated 
deadhesion 
  After plating suspended myeloid D2 cells in serum-free medium 
onto the culture dish, cells attached and exhibited spreading mor-
phology. Upon serum stimulation, these spreading cells contracted 
and became rounding, whereas the presence of Y27632, a ROCK 
  Figure 2.       Tyrosine phosphorylation of ROCKII.   (A) D2 cells were plated on hydrogel (HG) or FN-coated dishes in serum-containing medium 
for 2 h. Cells were treated with 50   μ  M pervanadate for 20 min and harvested for immunoprecipitation with anti-ROCKII (C-20) antibody or normal 
IgG. Western blots of the immunoprecipitates with anti-phosphotyrosine (4G10) antibody followed by reprobing with anti-ROCKII (H-85) antibody 
are shown. (B and C) HEK293T cells were transiently transfected with control vector or the expression plasmids of wild-type and various mutants 
of myc-ROCKII as indicated. Cells were treated with 100   μ  M pervanadate for 30 min before harvest for immunoprecipitation with anti-myc 
antibody or normal IgG. The immunoprecipitates were analyzed by Western blot as described in A. (D) Alignment of the vertebrate ROCKII se-
quence corresponding to the residues 712  –  732 of human ROCKII. Residues corresponding to Y722 of human ROCKII are indicated by asterisk 
and bold letters.     JCB • VOLUME 181 • NUMBER 6 • 2008  1002 
and examined their phosphorylation statuses when expressed 
in HEK293T cells. We found that the tyrosine phosphorylation 
signal was retained in the wild-type myc-ROCKII (6  –  1,388), 
myc-ROCKII (6  –  1,125), and myc-ROCKII (6  –  750) but not in 
myc-ROCKII (6  –  553;   Fig. 2 B  ). Our data indicated that the 
  tyrosine phosphorylation site is located within the coiled-coil 
region between aa 554 and 750 of ROCKII. Two tyrosine resi-
dues (Y692 and Y722) within this region were each mutated to 
phenylalanine. We found that Y722F mutation markedly dimin-
ished the tyrosine phosphorylation signal, whereas Y692F and 
Y936F mutations had no effect (  Fig. 2 C  ). Accordingly, we con-
clude that ROCKII is phosphorylated at the tyrosine 722 site. 
Sequence analysis showed that the surrounding sequence cover-
ing Y722 of ROCKII is highly conserved among different spe-
cies (  Fig. 2 D  ). 
  ROCKII is tyrosine phosphorylated 
 We then examined the possible existence of tyrosine-phosphory-
lated forms of ROCKs in suspended and adherent D2 cells. 
These cells were treated with another phosphatase inhibitor, 
pervanadate, for 20 min before immunoprecipitation followed 
by Western blot analysis, using phosphotyrosine-specifi  c mono-
clonal antibody 4G10. The result showed that endogenous 
ROCKII was indeed tyrosine phosphorylated. Interestingly, 
the tyrosine phosphorylation signal was increased with FN-
 mediated adhesion ( Fig. 2 A ). Because a small amount of endog-
enous ROCKI was immunoprecipitated by antibody against ROCKI 
in D2 cell extracts, we then focused on tyrosine phosphory-
lation of ROCKII for the rest of our study. To locate the region 
of the tyrosine phosphorylation site on ROCKII, we gener-
ated several deleted expression constructs of myc-ROCKII 
  Figure 3.       Y722 Phosphorylation reduces the level of ROCKII binding to GTP-RhoA.   (A) HEK293T cells expressing myc-ROCKII were treated with or without 
100   μ  M pervanadate (PV) for 30 min. Equal amounts of cell lysates were incubated with the indicated amount of GTP    S-loaded GST-RhoA protein followed 
by glutathione-Sepharose beads pulldown. A representative Western blot probed by myc antibody of the pulldown samples is shown at the top. Quantiﬁ  ca-
tion of amounts of myc-ROCKII in the pulldown materials relative to the total input from three independent experiments is shown at the bottom. The inset 
indicates the phosphorylation status of myc-ROCKII by 4G10 antibody. (B) Myc-ROCKII immunoprecipitates from pervanadate-treated cells were incubated 
with or without      protein phosphatase at 30  °  C for 20 min before incubation with 2   μ  g of GTP    S-loaded GST-RhoA protein for 30 min. After extensive 
wash, GST-RhoA protein pulled down by myc-ROCKII protein beads was detected by Western blotting with anti-RhoA antibody (top). *, heavy chain of IgG. 
Relative amount of RhoA pulled down by myc-ROCKII beads from three independent experiments is also shown (bottom). (C) Wild-type or Y722F mutant 
of myc-ROCKII from pervanadate-treated cells were used for the GTP    S-GST-RhoA pulldown assay. (D) Y722F and Y722D myc-ROCKII from cells without 
pervanadate treatment were used for GTP    S-GST-RhoA pulldown assay. All data are represented as mean   ±   SD (*, P   <   0.1; **, P   <   0.01;   n     ≥   3).     1003 ROCKII REGULATION BY SHP2   • Lee and Chang 
  Disrupting Y722 phosphorylation of 
ROCKII augments RhoA-dependent ROCK 
activation in cells 
  It has been shown that RhoA/ROCK signaling increases serum 
response factor (SRF)  –  dependent gene transcription (  Chihara 
et al., 1997  ). To ascertain that Y722 phosphorylation negatively 
regulates the RhoA-dependent ROCKII activation in vivo, 
we then compared serum-responsive element (SRE)  –  dependent 
transcriptional activities in cells expressing wild-type and Y722F 
ROCKII. In serum-starved fi  broblasts treated with nocodazole, 
RhoA is activated and stimulates focal adhesion and stress fi  ber 
formation (  Bershadsky et al., 1996  ;   Liu et al., 1998  ). Endogenous 
RhoA can be activated because of the release of GEF-H1 from 
microtubules (  Krendel et al., 2002  ;   Chang et al., 2006  ). We then 
used this experimental system to evaluate the functional effect 
of disrupting Y722 phosphorylation on the extent of ROCKII 
  Y722 phosphorylation decreases the 
binding capacity of ROCKII to 
GTP-bound RhoA 
  Given that pretreatment of cells with tyrosine phosphatase inhibi-
tor abolished RhoAV14-mediated cell detachment, it is possible 
that tyrosine dephosphorylation of ROCKII affects RhoA-depen-
dent activation of ROCKII. We then tested whether the status of 
ROCKII tyrosine phosphorylation affects its interaction with ac-
tive RhoA. To this end, HEK293T cells were transfected by the 
expression vector of myc-ROCKII and treated with or without 
pervanadate for 30 min before harvesting for GTP   S-loaded 
GST-RhoA binding assay. This RhoA binding activity assay was 
validated by the correlated amount of myc-ROCKII in GTP   S-
loaded GST-RhoA (active state) pulldown with the total input 
from untreated cells and the lack of ROCKII in the pulldown ma-
terials by GDP-loaded GST-RhoA (inactive state) beads (unpub-
lished data). As shown in   Fig. 3 A  , the GTP   S-RhoA  binding 
activity was reduced for ROCKII from pervanadate-treated cells 
in which ROCKII was phosphorylated. Similarly, ROCKI bind-
ing to RhoA-GTP was also sensitive to pervanadate pretreatment 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200710187/DC1). Removing tyrosine phosphorylation of myc-
ROCKII immunoprecipitates from pervanadate-treated cells by 
     protein phosphatase was capable of increasing the amount of 
GTP    S-RhoA binding to ROCKII, indicating the negative effect 
by tyrosine phosphorylation in RhoA binding (  Fig. 3 B  ). We also 
compared GTP    S-RhoA binding of wild-type and Y722F myc-
ROCKII expressed in cells treated with pervanadate. Equal 
amounts of cell lysates were incubated with increasing amounts 
of GTP    S-loaded GST-RhoA protein for pulldown assays. The re-
sults showed that more nonphosphorylable Y722F myc-ROCKII 
was pulled down by GTP    S-RhoA than wild-type myc-ROCKII 
at a different dosage of GTP    S-RhoA protein (  Fig. 3 C  ). More-
over, the amount of phosphomimetic Y722D mutant pulled down 
by GTP    S-RhoA at the lower dosage was also signifi  cantly less 
than that of nonphosphorylatable Y722F mutant (  Fig. 3 D  ). 
  RhoA-dependent ROCKII activation 
is sensitive to increased Y722 
phosphorylation 
 We further compared the kinase activities of wild-type and Y722F 
ROCKII in response to GTP    S-RhoA addition and pervanadate 
treatment. Cells expressing wild-type and Y722F ROCKII were 
treated with or without pervanadate before harvesting for immuno-
precipitation. The ROCKII immunoprecipitates were incubated 
with different amounts of GTP    S-GST-RhoA for kinase activity 
assay. Without pervanadate treatment to retain tyrosine phosphory-
lation, kinase activity of wild-type ROCKII was increased up 
to 2.5-fold by RhoA as compared with little induction of kinase 
activity by RhoA for ROCKII with tyrosine phosphorylation 
maintenance by pervanadate treatment. In contrast, kinase activity 
of Y722F ROCKII was increased by RhoA regardless of the per-
vanadate treatment (  Fig. 4 A  ). As compared with Y722F mutant, 
Y722D mutant showed less RhoA responsiveness in kinase acti-
vation (  Fig. 4 B  ). Collectively, these data demonstrate that RhoA-
dependent kinase activation of ROCKII is inversely correlated 
with its Y722 phosphorylation status. 
  Figure 4.       RhoA-dependent ROCKII activation is sensitive to Y722 dephos-
phorylation.   (A) In vitro kinase assay in the absence or presence of 0.1 
or 1   μ  M GTP    S-GST-RhoA protein with wild-type or Y722F myc-ROCKII 
immuno    precipitates from transfected cells treated with or without pervan-
adate. Inset indicates the phosphorylation status of ROCKII by Western 
  blotting with anti-pY (4G10) antibody. (B) Comparison of RhoA-dependent 
kinase activation of Y722F and Y722D myc-ROCKII. Data are expressed 
as fold increase relative to wild-type myc-ROCKII without GTP-RhoA stimu-
lation (mean   ±   SD; **, P   <   0.05).     JCB • VOLUME 181 • NUMBER 6 • 2008  1004 
the contribution of ROCK signaling in SRE-dependent transcrip-
tion. We also compared the effect of serum stimulation on SRF 
activation in cells expressing wild-type and Y722F ROCKII. 
ROCKII-dependent activation of SRF activation, as judged by 
the reporter activity sensitive to Y27632, after serum stimulation 
was also signifi  cantly higher in cells expressing Y722F mutant 
than in wild-type and control cells (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200710187/DC1). Thus, Y722F 
mutation renders ROCKII more active in stimulating SRF-
  mediated transcription in response to the RhoA signal. 
  To substantiate these observations, we further established 
NIH3T3 cells stably expressing wild-type and Y722F ROCKII. 
As expected, the steady-state level of MLC phosphorylation 
activation when endogenous RhoA activation was induced by 
microtubule disassembly. Expression vectors of wild-type and 
Y722F ROCKII were individually cotransfected with pSRE-
Luc reporter in NIH3T3 fi  broblasts to quantitatively compare 
the magnitude of RhoA-mediated ROCK activation. Endog-
enous RhoA activities in cells expressing wild-type and Y722F 
ROCKII were similarly elevated by nocodazole treatment for 4 h 
(  Fig. 5 A  ). However, RhoA-responsive SRE-dependent transcrip-
tion activity was increased 30-fold by nocodazole treatment in 
cells expressing Y722F ROCKII, as compared with a 10-fold in-
crease observed in control and wild-type ROCKII cells (  Fig. 5 B  ). 
Inhibition of ROCK by incubating cells with Y27632 abolished 
nocodazole-induced SRE-dependent transcription, confi  rming 
  Figure 5.       Disrupting Y722 phosphorylation 
of ROCKII augments RhoA-dependent ROCK 
activation in cells.   (A and B) NIH3T3 cells were 
cotransfected with pSRE-Luc, pCMV-HRC, and 
wild type, Y722F myc-ROCKII, or pcDNA3. 
After transfection for 24 h, cells were serum 
starved and treated with or without 10   μ  M of 
nocodazole for 4 h. (A) Endogenous RhoA 
activities in the cells were measured by GST-
RBD pulldown assay. A representative Western 
blot for the assay is shown on the left. Rela-
tive endogenous RhoA activity from three in-
dependent experiments is shown on the right. 
(B) Transfected cells were pretreated with or 
without 20   μ  M of Y27632 before nocodazole 
stimulation. The reporter activity was determined 
and expressed as induction folds relative to 
the nontreated cells. Values are mean   ±   SD 
of three independent experiments. (*, P   <   0.1). 
(C) NIH3T3 cells stably expressing wild-type 
or Y722F myc-ROCKII were selected and these 
cells were serum starved and treated with or 
without 10   μ  M of nocodazole for 1 h, ﬁ  xed, and 
stained with rhodamine-phalloidin and HOECHST 
33342. Bar, 20   μ  m. (D) A parallel set of cells 
were harvested for Western blot analysis. 
The relative ratio of phospho-MLC to total MLC 
is shown below. (E) Cells were trypsinized 
and replated to culture dishes and monitored 
for 5 h by time-lapse microscopy. Areas of 
spreading were measured using MetaMorph 
software and expressed as mean   ±   SD. (F) A 
parallel set of cells were treated with Y27632 
for the spreading assay. Videos 1 and 2 (avail-
able at http://www.jcb.org/cgi/content/full/
jcb.200710187/DC1) correspond to E and 
F, respectively.     1005 ROCKII REGULATION BY SHP2   • Lee and Chang 
activated by RhoA, these fi  broblasts would become rounding 
in response to microtubule disassembly. In fact, fi  broblasts ex-
pressing wild-type ROCKII continued to spread after nocodazole 
was increased in Y722F cells with a stronger stress fi  ber forma-
tion (  Fig. 5, C and D  ). These cells were then treated with no-
codazole to stimulate endogenous RhoA. If ROCKII is readily 
  Figure 6.       Y722 phosphorylation of ROCKII is associated with cell adhesion.   (A) D2 cells in suspension and plated onto FN-coated coverslips for 0.5 and 2 h 
were ﬁ  xed and stained with anti-pY722ROCKII antibody, which had been preincubated with or without 1   μ  g/ml of Y722 peptide or pY722 peptide. Insets 
show enlargements of the boxed ares. Bar, 20   μ  m. (B) D2 cells were transfected with the pEGFP and wild-type or Y722F myc-ROCKII (1:5 ratio). Transfected 
cells were plated on FN-coated dishes and monitored by time-lapse microscopy for 60 min after plating. Arrows indicate the GFP-positive transfected cells. 
Video 3 (available at http://www.jcb.org/cgi/content/full/jcb.200710187/DC1) corresponds to this ﬁ  gure. Bars, 20   μ  m. (C) Transfected cells, as described 
in B, were preincubated with or without 2 mM MnCl  2   or 20   μ  M Y27632 for 30 min and then assayed for their adhesion to FN-coated plates within 30 min as 
described in Materials and methods. Data are represented as mean   ±   SD (**, P   <   0.05). (D) NIH3T3 cells were transfected with the expression vector of GFP-
paxillin. After serum starvation, cells were treated with 10   μ  M nocodazole for 1 h and ﬁ  xed for immunoﬂ  uorescence staining of pY722-ROCKII. Bar, 20   μ  m.     JCB • VOLUME 181 • NUMBER 6 • 2008  1006 
treatment, indicating that the level of ROCKII activation by this 
RhoA signaling does not generate enough contraction force to 
dissociate molecular linkage for adhesion. In contrast, Y722F 
cells become rounding after nocodazole treatment, which is an 
indication of more contractility generated from RhoA/ROCKII 
activation (  Fig. 5 C  ). To know whether loss of Y722 phosphory-
lation affects cell spreading, we measured the spreading rate of 
NIH3T3 cells stably expressing wild-type and Y722F ROCKII 
during adhesion. When plated onto culture dishes, Y722F fi  bro-
blasts spread slower than wild-type cells. With Y27632 pretreat-
ment, these cells spread at a similar rate (  Fig. 5, E and F  ; and 
Videos 1 and 2, available at http://www.jcb.org/cgi/content/full/
jcb.200710187/DC1). It is likely that Y722 phosphorylation of 
ROCKII plays a role in the spreading process. 
  Y722 phosphorylation of ROCKII 
in adhesion 
  Next, we generated antibody specifi  cally recognizing phosphory-
lated Y722 peptide. Fig. S3 (available at http://www.jcb.org/
cgi/content/full/jcb.200710187/DC1) shows the characterization 
of this antibody, which was then used for immunofl  uorescence 
staining of D2 cell transition from suspension to adhering onto 
FN-coated plates. The immunofl  uoresence staining revealed a 
clear punctate pattern in the peripheral membrane protrusion areas 
of D2 cells that were adhering to FN-coated dishes for 0.5 or 2 h 
(  Fig. 6 A  ). The staining signal was neutralized by phosphorylated 
Y722 peptide but not by unphosphorylated peptide, indicating 
the specifi  city of this antibody in detecting Y722-phosphorylated 
ROCKII. The intensity of Y722-phosphorylated ROCKII was in-
creased in D2 cells during transition from suspension to adhesion 
(  Fig. 6 A  ). A similar punctate staining pattern was also observed 
in HEK293T cells, and ROCKII depletion by siRNA signifi  cantly 
diminished this staining pattern, confi  rming the specifi  city of this 
antibody in detecting phosphorylated Y722 ROCKII in the pe-
ripheral membrane protrusion areas (Fig. S3 D). Some residual 
staining in ROCKII-depleted cells could be caused by either in-
complete knockdown or a low level of nonspecifi  c reactivity. 
Having found that Y722 phosphorylation is increased with cell 
adhesion without pervanadate stimulation, we then assessed 
whether Y722 dephosphorylation of ROCKII affects deadhesion 
and adhesion. D2 cells were transfected with wild-type and 
Y722F ROCKII expression vectors and plated onto FN-coated 
dishes in the presence of serum for time-lapse video recording. 
The successfully transfected cells were indicated by green fl  uo-
rescence from cotransfected pEGFP. By 20 min, cells expressing 
wild-type ROCKII readily adhered and spread onto FN matrix, 
whereas Y722F cells remained fl  oating and did not adhere to 
spread until 60 min of plating (  Fig. 6 B   and Video 3, available at 
http://www.jcb.org/cgi/content/full/jcb.200710187/DC1). Quanti-
tative analysis of the cell number adhering to FN-coated dishes 
after seeding for 30 min showed that expression of Y722F mutant 
signifi  cantly delayed D2 cell adhesion onto the FN matrix ( Fig. 6 C ). 
Previously, we used antibody blocking    1-integrin  and  found 
that FN-mediated adhesion for D2 cells is   1-integrin – dependent 
(unpublished data). Considering the possibility that expression 
of Y722F ROCKII might directly affect integrin function of D2 
cells, we then pretreated the transfected cells with MnCl  2,   which 
locks     1-integrin in active conformation (  Gailit and Ruoslahti, 
1988 ).  MnCl 2   pretreatment restored the adhesion ability of D2 
cells expressing Y722F ROCKII, indicating that the decrease of 
adhesion is not caused by a functional defect of    1-integrin. 
Y27632 treatment had a similar effect to MnCl  2 ,  demonstrating 
that gain of ROCKII function by Y722F mutation makes cells 
less susceptible for FN-mediated integrin activation (  Fig. 6 C  ). 
We also transfected NIH3T3 cells with expression vector of GFP-
paxillin, an indicator of focal adhesion contact sites, followed by 
immunofl  uorescence staining using antibody against phosphory-
lated Y722 ROCKII. The result showed colocalization of Y722-
phosphorylated ROCKII with GFP-paxillin, suggesting that Y722 
phosphorylation of ROCKII is specifi  ed in the focal adhesion 
contact sites (  Fig. 6 D  ). 
  Shp2 is essential for ROCK-dependent 
deadhesion in response to RhoA activation 
 Because RhoA-dependent activation of ROCKII is interfered with 
by inhibition of phosphatase, we further addressed the question of 
which phosphatase is involved in its activation during deadhesion. 
It is well established that Shp2 is a tyrosine phosphatase involved 
in regulation of focal adhesion turnover and cell motility. We then 
tested whether Shp2 is involved in the RhoAV14-induced cell 
detachment. Cells expressing GFP-RhoAV14 showed round-
ing morphology, whereas coexpression of catalytic-inactive 
Shp2(C/S) prevented GFP-positive cells from rounding. In con-
trast, coexpression of another catalytic-dead tyrosine phosphatase, 
PTP-1B (C/S), had no effect on inhibiting RhoAV14-induced 
rounding. (  Fig. 7, A and B  ). Expression of the constitutive-active 
form of ROCKII (ROCKII(CAT)) induced cell rounding regard-
less of Shp2(C/S) expression (  Fig. 7 C  ), suggesting that Shp2 is an 
upstream regulator for ROCK activation in RhoAV14-induced cell 
rounding. Shp2(C/S) expression or Shp2 knockdown by siRNA 
in HEK293T cells also impaired RhoAV14-induced cell detach-
ment and stimulation of MLC phosphorylation (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710187/DC1), 
confi  rming the functional involvement of Shp2 in RhoA-dependent 
ROCK activation. Furthermore, expression of gain-of-function 
Shp2 (E76G) mutant in D2 cells also reduced cell adhesion onto 
FN-coated dishes in a Y27632-sensitive manner, indicating that 
active Shp2 induction of cell deadhesion is dependent on ROCK 
activity (  Fig. 7 D  ). 
  We also tested the inhibitory effect of Shp2(C/S) ex-
pression on serum-induced rounding in D2 cells transfected 
with wild-type and Y722F ROCKII. The transfected cells were 
plated onto the culture dishes in serum-free medium to   allow 
cells spreading. Transfected cells indicated by green fl  uo-
rescence positivity were counted before a 20% serum addition 
to induce cell rounding. Thereafter, spreading and rounding 
green fl  uorescence  –  positive cells were counted. Expression of 
Shp2(C/S) signifi  cantly prevented cells expressing wild-type 
ROCKII from serum-induced rounding. In contrast, cells ex-
pressing Y722F ROCKII were insensitive to Shp2(C/S) expression 
and underwent serum-induced rounding (  Fig. 7, E and F  ). 
  Accordingly, Y722F represents a gain-of-function mutation for 
ROCKII, which dispenses the requirement of Shp2-mediated 
dephosphorylation for its activation. 1007 ROCKII REGULATION BY SHP2   • Lee and Chang 
between a phosphatase and its substrate, Shp2 trapping mutant, 
which carries D425A/C459S mutation, was used to test for its 
interaction with ROCKII. We isolated fl  ag-tagged  wild-type 
and trapping mutant Shp2 proteins expressed in HEK293T cells 
  ROCKII is a substrate of Shp2 that 
mediates Y722 dephosphorylation 
  Next, we assessed whether ROCKs would be the direct sub-
strates of Shp2. On the basis of the transient interaction nature 
  Figure 7.       Shp2 is essential for ROCK-dependent rounding in response to RhoA activation.   (A) Fluorescent and phase-contrast image of D2 cells transfected 
with expression vector of pGFP-RhoAV14 and ﬂ  ag-Shp2(C/S) or PTP1B(C/S) (amount of DNA ratio at 1:5) as indicated and plated onto FN-coated cover-
slip for 30 min. Bar, 20   μ  m. (B) The percentages of GFP(+) cells spreading on coverslips in total GFP(+) cells were counted and calculated. (C) D2 cells 
transfected by pEGFP, pMyc-ROCKII(CAT) with or without pﬂ  ag-Shp2(C/S) (amount of DNA ratio at 1:3:12) were analyzed for spreading on FN-coated 
coverslips. (D) D2 cells were cotransfected with the expression vectors of GFP and Shp2 E76G or pcDNA3 and were treated with MnCl  2   or Y27632, as 
indicated, before being plated onto FN-coated coverslips. Relative number of GFP(+) cells spreading on FN-coated coverslips within 30 min was deter-
mined. (E) Cells transfected by pEGFP, wild-type, or Y722F pMyc-ROCKII with or without pﬂ  ag-Shp2(C/S) (DNA ratio at1:2:4) were plated onto dish in 
serum-free medium. After 6 h of incubation, cells were stimulated with or without 20% of serum for 10 min. Cells were imaged by ﬂ  uorescence microscopy. 
Bar, 50   μ  m. (F) The rounding percentage of total GFP(+) cells was calculated. All data are represented as mean   ±   SD (**, P   <   0.05).     JCB • VOLUME 181 • NUMBER 6 • 2008  1008 
stimulated by pervanadate treatment. Trapping mutant, but not 
wild-type, Shp2 was able to pull down wild-type ROCKII. 
This approach also allowed FAK, a known substrate of Shp2 
by M2 agarose beads, separately. Each set of protein beads were 
incubated with equal amounts of cell lysates from HEK293T 
cells expressing wild-type or Y722F ROCKII, which had been 
  Figure 8.       ROCKII is a substrate of Shp2 that mediates Y722 dephosphorylation.   (A) In vitro substrate trapping assay. Wild-type (WT), substrate trapping 
mutant (DM) ﬂ  ag-Shp2, and control beads, as indicated, were incubated with lysates from pervanadate-treated cells expressing wild-type or Y722F myc-
ROCKII. The pulldown proteins were analyzed by Western blotting. (B) Shp2 dephosphorylates ROCKII in vitro. Immunoprecipitated myc-ROCKII protein 
from pervanadate-treated cells was incubated with increasing amounts of GST-N-del Shp2(PTP) at 30  °  C for 0  –  20 min and analyzed by Western blotting. 
(C) HEK293T cells were transfected with control or Shp2 siRNA for 2 d and replated to FN-coated coverslips for 0.5 or 2 h or trypsinized after 2 h of FN-
mediated adhesion. Cells were ﬁ  xed and subjected to pY722-ROCKII immunoﬂ  uorescence staining. The percentage of trypsinized cells that were positive in 
pY722-ROCKII staining is shown below. Bar, 20   μ  m. (D) Immunoﬂ  uorescence images of pY722 ROCKII in siRNA transfected HEK293T cells on FN-coated 
coverslips with TAT-RhoAV14 treatment at the indicated time. (E) Western blot of siRNA transfected cells.     1009 ROCKII REGULATION BY SHP2   • Lee and Chang 
of ROCKII regardless of pervanadate treatment. The difference 
in the extent of RhoA-GTP binding ability correlates with the 
corresponding kinase activity between phosphorylated or un-
phosphorylated forms of ROCKII. Because the kinase activity 
of a phosphomimetic mutant Y722D is much less responsive 
to RhoA stimulation, we conclude that Y722 phosphorylation 
  negatively modulates ROCKII binding to active form of RhoA, 
thereby attenuating its kinase activity. In other words, when 
a limiting amount of RhoA is activated, ROCKII with Y722 
phosphorylation is less active as compared with unphosphory-
lable Y722F mutant in its kinase activation. However, it remains 
an open question whether Y722 phosphorylation affects RhoA 
binding through an interacting protein or simply as a result of 
conformational change that hampers the accessibility of the 
RBD to RhoA. Another important question is whether ROCKI 
binding to GTP-RhoA is also regulated by tyrosine phosphory-
lation. Like ROCKII, the endogenous amount of ROCKI in HeLa 
cells and myc-ROCKI expressed in HEK293T cells pulled down 
by GST-RhoA-GTP was also sensitive to pervanadate treatment, 
and tyrosine phosphorylation was detected in ROCKI immuno-
precipitate (Fig. S1). Together with the result showing that the 
substrate trapping mutant Shp2 is able to pull down ROCKI in 
adherent D2 cell lysates (Fig. S5), the negative control by tyro-
sine phosphorylation is probably also true for ROCKI regula-
tion. Because ROCKI does not have a corresponding Y residue, 
its tyrosine phosphorylation site remains to be determined. 
  In this study, we observed a higher level of tyrosine 
phosphorylation of ROCKII in adherent than suspension D2 
cells, implying that ROCKII is phosphorylated at the time of ad-
hesion. Of note, Y722 phosphorylated ROCKII was mainly de-
tected in the peripheral protruding regions in spreading cells. 
As indicated by colocalization with GFP-paxillin in spreading 
NIH3T3 fi  broblasts, it is apparent that Y722 phosphorylation of 
ROCKII is particularly enriched in the focal adhesion contact 
sites. It is likely that the action by tyrosine kinase in the adhesion 
contact sites makes ROCKII tyrosine phosphorylated to become 
less active. Actomyosin-based contractility stimulated by MLC 
phosphorylation has been shown to be necessary for the focal adhe-
sion formation. Treatments of cells with inhibitors of contractility, 
( Tsutsumi et al., 2006 ), in the lysates to be pulled down by trapping 
mutant but not by wild-type Shp2, indicating the specifi  c inter-
acting relationship between the phosphosubstrate and phospha-
tase at the active site rather than an Shp2-containing complex 
formation. Very little amount of Y722F mutant was pulled down 
by the trapping mutant Shp2 protein, indicating the specifi  c 
interaction between phosphorylated Y722 with the Shp2 cata-
lytic site (  Fig. 8 A  ). Interestingly, ROCKI was similarly pulled 
down by trapping Shp2 mutant protein (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200710187/DC1). 
We further incubated immunoprecipitated phosphorylated ROCKII 
with recombinant N-deleted Shp2 protein to test whether ROCKII 
can be a direct in vitro substrate of Shp2. The results showed an 
increase of ROCKII dephosphorylation by N-del Shp2 in a dose- 
and time-dependent manner (  Fig. 8 B  ). 
  We then tested the effect of Shp2 depletion in HEK293T 
cells on ROCKII Y722 phosphorylation during cell spreading 
and rounding. When adhering to FN-coated dishes, cells depleted 
of Shp2 spread more with increased punctate staining of Y722-
phosphorylated ROCKII in the protruding edges. Because it has 
been shown that RhoA/ROCK contractility is increased during 
cell rounding upon trypsinization (  Ren et al., 1999  ;   Maddox and 
Burridge, 2003  ), we then examined the involvement of Shp2 in 
ROCKII Y722 dephosphorylation in response to trypsinization. 
The immunofl   uorescence staining data showed that Y722 
phosphorylation of ROCKII became diminished in the newly 
rounding HEK293T cells after trypsinization, whereas a signifi  -
cant proportion of cells depleted of Shp2 were still positive in 
Y722-phosphorylated ROCKII staining (  Fig. 8 C  ). With TAT-
RhoAV14 treatment to induce detachment, the staining signal of 
Y722-phosphorylated ROCKII was still retained in cells de-
pleted of Shp2 but not in control cells (  Fig. 8 D  ). Together, these 
results indicated that Shp2 participates in Y722 dephosphoryla-
tion of ROCKII during cell rounding. 
  Discussion 
  In this paper, we show for the fi  rst time that ROCKII activation by 
RhoA is negatively modulated by Y722 phosphorylation, provid-
ing an additional layer of control that the extent of ROCKII activa-
tion can be uncoupled with RhoA signaling. In addition, this paper 
adds ROCKII to the substrate list of Shp2, which dephosphorylates 
ROCKII at the Y722 site and participates in the process of RhoA-
dependent ROCKII activation during cell deadhesion. In this paper, 
we postulate that reversible modifi  cation of ROCKII by tyrosine 
phosphorylation dynamically regulates RhoA/ROCK-mediated 
contractility, by which ROCK is fi  ne-tuned in a spatiotempo-
ral manner during adhesion and spreading (  Fig. 9  ). 
  Because Y722 is neither located within the kinase region 
nor the RBD of ROCKII, an important question is how Y722 
phosphorylation negatively controls the ROCKII function. To ad-
dress this question, we have compared the RhoA-GTP binding 
activity of ROCKII, which is maintained tyrosine phosphory-
lated by pervanadate treatment. Our results showed that the 
GTP-RhoA binding activity of ROCKII was reduced by mainte-
nance of Y722 phosphorylation. Substitution of tyrosine 722 by 
phenylalanine elevated RhoA-GTP binding and kinase activities 
  Figure 9.       Model of regulation of ROCKII by reversible tyrosine phos-
phorylation.   Y722 phosphorylation by a kinase in focal contacts de-
creases ROCKII binding afﬁ  nity to RhoA. Dephosphorylation of ROCKII 
by Shp2 stimulates its RhoA binding activity, thereby increasing acto-
myosin contractility.     JCB • VOLUME 181 • NUMBER 6 • 2008  1010 
2007  ;   Mohi and Neel, 2007  ). One study has demonstrated that ex-
pression of gain-of-function mutant Shp2 E76A can still increase 
SRF-mediated c-  fos   SRE reporter transcription even in the pres-
ence of dominant-active RhoA in lymphocyte after IL-2 stimula-
tion, indicating additional up-regulation of ROCK-mediated SRF 
activation by Shp2 activation (  Arnaud et al., 2004  ). In this study, 
we showed that expression of another gain-of-function mutant, 
Shp2 E76G, in D2 cells decreased cell adhesion onto FN in a 
Y27632-sensitive manner. Conversely, disruption of Shp2 function 
abolished RhoA-induced deadhesion. Because regulation of adhe-
sion and deadhesion is also an important process for hematopoiesis, 
this study also provokes the question of whether Shp2-mediated 
regulation of ROCK is critical for myelopoiesis and erythropoiesis 
and is involved in leukemia development associated with gain-of-
function mutation of Shp2. 
  Materials and methods 
  Plasmids 
  pcDNA3-myc-ROCKII (6  –  553), (6  –  750), and (6  –  1,125) were constructed 
by insertion of the corresponding cDNA fragments derived from pEF-myc-
ROCKII (6  –  1,388, wild type; obtained from K. Kaibuchi, Nara Institute of 
Science and Technology, Ikoma, Japan) into pcDNA3 vector. The Y692F, 
Y722F, Y722D, and Y936F mutations were individually introduced to pEF-
myc-ROCKII (6  –  1,388) using the Quick-Change site-directed mutagenesis 
kit (Stratagene). Expression construct of paxillin (obtained from R.H. Chen 
Institute of Biochemistry, Academia Sinica, Taipei, Taiwan) was subcloned 
into pEGFP vector. Expression constructs of wild-type and C459S Shp2 
(obtained from T.C. Meng, Institute of Biochemistry, Academia Sinica, Tai-
pei, Taiwan) were subcloned into pﬂ  ag-CMV2 vector. The double mutant of 
Shp2 (D425A and C459S) was generated by site-directed mutagenesis. 
Expression construct of Shp2 E76G was obtained from J.Y. Chen (Depart-
ment of Hematology, National Taiwan University Hospital, Taipei, Taiwan). 
The expression construct of myc-ROCKI was provided by J. Hamelin 
(INSERM U461, Facult  é   de Pharmacie, Ch  â  tenay-Malabry, France) The 
cDNA of RhoA (wild type) and RhoAV14 was cloned into pGEX-2T and 
pTAT-HA vector to generate pGEX-RhoA and pTAT-RhoAV14, respectively. 
  Antibodies and reagents 
  Y-27632 was obtained from EMD; anti  –  phospho-MLC2 (T 
18  /S 
19  ) antibody was 
obtained from Cell Signaling Technology; anti-MLC, anti-HA, anti  –      -actin, 
and anti  –      -tubulin antibodies and rhodamine-phalloidin were obtained 
from Sigma-Aldrich; anti-ROCKII and anti-RhoA antibodies were purchased 
from Santa Cruz Biotechnology, Inc.; anti-phosphotyrosine (clone 4G10) anti-
body was obtained from Millipore; and anti-myc antibody was puriﬁ  ed from 
hybridoma clone 9E10. TAT-RhoAV14 protein was puriﬁ  ed as previously re-
ported (  Chang et al., 2006  ). The recombinant N-del Shp2 protein was pur-
chased from Abcam. The siRNA targeting human Shp2 was obtained from 
Thermo Fisher Scientiﬁ  c. The anti-pY722ROCKII antibody was raised using 
phosphopeptide Ac-LADKNKI(pY)ESIEEAC-amide and afﬁ  nity puriﬁ  ed by the 
phosphopeptide column with the removal of the nonphospho antibodies 
(Quality Controlled Biochemicals). Of note, this antibody was able to detect 
a drastically increased signal of Y722 phosphorylated ROCKII in cells after 
pervanadate treatment. In particular, the strong immunoﬂ  uorescence staining 
of Y722-phosphorylated ROCKII was all over the membrane periphery in 
pervanadate-treated HEK293T cells, which was a contrast to the weak ﬂ  uo-
rescence intensity in punctate pattern seen in untreated cells (Fig. S3). 
  Cell culture and transient transfection 
  D2 cells were cultured in RPMI1640 containing 10% heat-inactivated FBS. 
HEK293T and NIH3T3 cells were maintained in DME containing 10% FBS 
or calf serum. For transient transfection experiments, HEK293T and NIH3T3 
cells were transfected by Lipofectamine reagent (Invitrogen). D2 cells were 
transfected by MicroPorator MP-100 (Digital Bio Technology). For siRNA 
transfection experiment, HEK293T cells were transfected by Lipofectamine 
2000 reagent. 
  Endogenous RhoA activity and RhoA  –  ROCK interaction assays 
  GST-RBD afﬁ  nity precipitation of cellular GTP-bound RhoA was used to 
assay endogenous RhoA activity as described by   Ren and Schwartz (2000)  . 
such as BDM and MLC kinase inhibitor, cause the dissociation 
of periphery focal adhesions. However, inhibition of ROCK dis-
rupts focal adhesions in the central region rather than in the peri-
phery (  Totsukawa et al., 2004  ), implying that ROCK-mediated 
contractility is not involved in the assembly of focal adhesion in 
the periphery region where RhoA is consistently activated for 
microtubule stabilization via RhoA/Dia signaling (  Palazzo et al., 
2004  ). Our data showing that ROCK Y722 phosphorylation is 
specifi  ed in the focal contacts in the cell periphery suggest that 
Y722 phosphorylation plays a role in restricting ROCK activation 
in a spatial manner for the maturation of focal contact formation in 
cell spreading. Because RhoA/Dia signaling for microtubule sta-
bilization is essential for cell motility, it is possible that negative 
control by Y722 phosphorylation provides a means to have Dia 
preferentially activated in a spatiotemporal manner so that ROCK 
is uncoupled with the RhoA signal precisely. In support of this 
hypothesis, we found that NIH3T3 fi  broblasts expressing Y722F 
ROCKII also spread slower, as compared with the cells expressing 
similar levels of wild-type ROCKII. Likewise, expression of 
Y722F mutant retards D2 cell adhering to FN-coated dish, indi-
cating that the decrease in FN-mediated adhesion is closely asso-
ciated with lack of Y722 phosphorylation. Both in vitro and in vivo 
data are consistent with the scenario that Y722 phosphorylation 
plays a role in optimizing ROCKII-mediated contractility for 
adhesion and spreading. Upon deadhesion signal, ROCKII might 
become dephosphorylated, thereby increasing its RhoA binding 
activity. As a result, ROCKII becomes fully activated to generate 
contraction force, disrupting the linkage between integrin and 
  matrix to cause rounding for detachment. 
  Although the kinase in the adhesion complex for ROCKII 
phosphorylation remains to be defi  ned, our experimental data 
indicate that Shp2 is required for dephosphorylation of ROCKII 
in response to the deadhesion signal. Probably, the kinase and 
Shp2 work dynamically in the adhesion contact sites so that the 
contraction force generated by local ROCKII activity can be 
precisely regulated without turning RhoA signaling off or on. 
Shp2-defi  cient fi  broblasts or MCF-7 cells expressing dominant-
negative Shp2(C/S) display reduced cell motility and enhanced 
focal adhesion (  Yu et al., 1998  ;   Manes et al., 1999  ;   Inagaki 
et al., 2000  ), suggesting that Shp2 plays an important role in the 
control of cell spreading and migration. It has been demon-
strated that the function of Shp2 in cell motility involves FAK 
dephosphorylation, which is the signal that turns off the focal 
adhesion contact for local detachment ( von Wichert et al., 2003 ). 
Our results showing that expression of Y722F ROCKII reverses 
the inhibitory effect of loss of Shp2 function on serum-stimulated 
cell rounding suggest that the action of Shp2 on ROCKII dephos-
phorylation is necessary for cell rounding. Given the fact that 
ROCKII phosphorylation is associated with adhesion-detachment 
signaling pathways necessary for cell motility, Shp2 effect on cell 
motility might be related to the control of ROCKII dephosphory-
lation. Collectively, we proposed that the Shp2 might dephos-
phorylate ROCKII and FAK in a concerted manner to result in 
focal adhesion turnover for cell migration. 
 Shp2  defi  ciency causes defect in myelopoiesis and erythro-
poiesis in the mice model ( Qu et al., 1997 ). Gain-of-function muta-
tion of Shp2 is associated with several leukemias (  Chan and Feng, 1011 ROCKII REGULATION BY SHP2   • Lee and Chang 
ing Center, Core laboratory 2, National Taiwan University Hospital) for 
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cal support. 
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